UC San Diego researchers have settled a decades-long debate surrounding the role of the first Crohn's disease gene to be ...

UC San Diego researchers have resolved a decades-long debate about the role of the first Crohn’s disease gene linked to an increased risk of developing the autoimmune condition. The human digestive ...

People with Crohn’s disease often take medicines to help manage their condition and improve their symptoms. Some of these medicines are taken by mouth and stay inside of the digestive tract. But ...

UC San Diego researchers combined artificial intelligence with molecular biology to unravel how immune cells in the gut ...

Artificial intelligence helps UCSD scientists discover a biological process connected to the bowel disease, potentially ...

How Does Tremfya Work for Crohn's Disease? Tremfya is a type of medicine called a monoclonal antibody. It works by targeting a protein in your body called interleukin-23 (IL-23). IL-23 is a cytokine ...

Crohn’s colitis is a type of Crohn’s disease that only affects the colon, or large intestine. It differs from other types of ...

Older patients with Crohn’s disease had a milder postoperative clinical course but significantly higher 5-year mortality than ...

Up to 40% of IBD patients may experience EIMs, with higher risks in Crohn disease and specific disease locations. Five key risk factors for EIMs include disease type, sex, ocular manifestations, ...

for adults with moderately to severely active ulcerative colitis, maker Eli Lilly announced. Phase IV data on vedolizumab ...

Crohn’s disease is an autoimmune condition that causes symptoms like diarrhea and abdominal pain. Irritable bowel syndrome (IBS) can cause similar symptoms as well as constipation. Many ...